| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4405112
[patent_doc_number] => 06171855
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Vectors'
[patent_app_type] => 1
[patent_app_number] => 9/085848
[patent_app_country] => US
[patent_app_date] => 1998-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8082
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/171/06171855.pdf
[firstpage_image] =>[orig_patent_app_number] => 085848
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/085848 | Vectors | May 27, 1998 | Issued |
Array
(
[id] => 4386369
[patent_doc_number] => 06278039
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'C. elegans deletion mutants'
[patent_app_type] => 1
[patent_app_number] => 9/085476
[patent_app_country] => US
[patent_app_date] => 1998-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 13450
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/278/06278039.pdf
[firstpage_image] =>[orig_patent_app_number] => 085476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/085476 | C. elegans deletion mutants | May 26, 1998 | Issued |
| 09/084219 | IDENTIFICATION AND PURIFICATION OF HIGHER ORDER TRANSCRIPTION COMPLEXES FROM TRANSGENIC NON-HUMAN ANIMALS | May 25, 1998 | Abandoned |
| 09/079877 | TRANSGENIC ANIMALS PRODUCED BY HOMOLOGOUS SEQUENCE TARGETING | May 14, 1998 | Abandoned |
Array
(
[id] => 1350355
[patent_doc_number] => 06583333
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-24
[patent_title] => 'Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomas'
[patent_app_type] => B1
[patent_app_number] => 09/076776
[patent_app_country] => US
[patent_app_date] => 1998-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 16
[patent_no_of_words] => 8789
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/583/06583333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09076776
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/076776 | Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomas | May 11, 1998 | Issued |
| 09/076369 | MULTIVIRAL COMPOSITIONS THEREOF | May 10, 1998 | Abandoned |
| 09/072275 | USE OF CYTOPLASMIC ANTIPROTEINASE-3 AND CODING SEQUENCES IN GENE THERAPY | May 3, 1998 | Abandoned |
Array
(
[id] => 4118451
[patent_doc_number] => 06046381
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Apolipoprotein E transgenic mice and assay methods'
[patent_app_type] => 1
[patent_app_number] => 9/070670
[patent_app_country] => US
[patent_app_date] => 1998-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 18
[patent_no_of_words] => 14232
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046381.pdf
[firstpage_image] =>[orig_patent_app_number] => 070670
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/070670 | Apolipoprotein E transgenic mice and assay methods | Apr 29, 1998 | Issued |
Array
(
[id] => 1408089
[patent_doc_number] => 06528303
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Neuropeptide Y-Y5 receptor'
[patent_app_type] => B1
[patent_app_number] => 09/065027
[patent_app_country] => US
[patent_app_date] => 1998-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 12
[patent_no_of_words] => 8349
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09065027
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/065027 | Neuropeptide Y-Y5 receptor | Apr 21, 1998 | Issued |
Array
(
[id] => 1080409
[patent_doc_number] => 06835567
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-12-28
[patent_title] => 'PNS cell lines and methods of use therefor'
[patent_app_type] => B1
[patent_app_number] => 09/060409
[patent_app_country] => US
[patent_app_date] => 1998-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 68
[patent_no_of_words] => 13669
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835567.pdf
[firstpage_image] =>[orig_patent_app_number] => 09060409
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/060409 | PNS cell lines and methods of use therefor | Apr 13, 1998 | Issued |
| 09/058160 | USE OF MARROW-DERIVED GLIAL PROGENITOR CELLS AS GENE DELIVERY VEHICLES INTO THE CENTRAL NERVOUS SYSTEM | Apr 9, 1998 | Abandoned |
| 09/055090 | RIBOZYME-MEDIATED CONTROL OF GENE EXPRESSION | Apr 2, 1998 | Abandoned |
| 09/052864 | HUMAN TELOMERASE CATALYTIC SUBUNIT VARIANTS | Mar 30, 1998 | Abandoned |
Array
(
[id] => 4161203
[patent_doc_number] => 06114599
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-05
[patent_title] => 'Recombinant .beta.-cell and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/044297
[patent_app_country] => US
[patent_app_date] => 1998-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 5
[patent_no_of_words] => 5669
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/114/06114599.pdf
[firstpage_image] =>[orig_patent_app_number] => 044297
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/044297 | Recombinant .beta.-cell and uses thereof | Mar 18, 1998 | Issued |
Array
(
[id] => 561504
[patent_doc_number] => 07157615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Production of biofilaments in transgenic animals'
[patent_app_type] => utility
[patent_app_number] => 09/040518
[patent_app_country] => US
[patent_app_date] => 1998-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8799
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157615.pdf
[firstpage_image] =>[orig_patent_app_number] => 09040518
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/040518 | Production of biofilaments in transgenic animals | Mar 16, 1998 | Issued |
Array
(
[id] => 4375767
[patent_doc_number] => 06261554
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Compositions for targeted gene delivery'
[patent_app_type] => 1
[patent_app_number] => 9/000133
[patent_app_country] => US
[patent_app_date] => 1998-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10980
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/261/06261554.pdf
[firstpage_image] =>[orig_patent_app_number] => 000133
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/000133 | Compositions for targeted gene delivery | Feb 23, 1998 | Issued |
| 09/020179 | HUMAN NERVE GROWTH FACTOR EXON 1 AND EXON 3 PROMOTERS | Feb 5, 1998 | Abandoned |
Array
(
[id] => 6291476
[patent_doc_number] => 20020055474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'NOVEL MOLECULES OF THE TNF LIGAND SUPERFAMILY AND USES THEREFOR'
[patent_app_type] => new
[patent_app_number] => 09/014348
[patent_app_country] => US
[patent_app_date] => 1998-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 32901
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055474.pdf
[firstpage_image] =>[orig_patent_app_number] => 09014348
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/014348 | NOVEL MOLECULES OF THE TNF LIGAND SUPERFAMILY AND USES THEREFOR | Jan 26, 1998 | Abandoned |
Array
(
[id] => 4292275
[patent_doc_number] => 06197551
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Spoil-1 protein and nucleic acid molecules and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/013810
[patent_app_country] => US
[patent_app_date] => 1998-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 3
[patent_no_of_words] => 31380
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197551.pdf
[firstpage_image] =>[orig_patent_app_number] => 013810
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/013810 | Spoil-1 protein and nucleic acid molecules and uses therefor | Jan 26, 1998 | Issued |
| 09/013508 | METHOD OF SCREENING FOR NEUROPHARMACEUTICALS USING THE DROSOPHILA GENE VOLADO AND ITS MUTANTS | Jan 25, 1998 | Abandoned |